Abstract: Objective Aquaporin-4 (AQP4), the main water channel protein in the brain, plays a critical role in water homeostasis and brain edema. Here, we investigated its role in the inflammatory responses after focal cerebral ischemia.
Introduction
Aquaporin-4 (AQP4), the water channel protein mainly expressed in the brain [1, 2] , is primarily localized in astrocytes [3] and plays a critical role in water homeostasis and edema in the brain [2] . From the investigations of AQP4-deficient mice, AQP4 has been found to promote cytotoxic edema but attenuate vasogenic edema after brain injury [4] .
In addition, AQP4 is a regulator in processes unrelated to edema, such as astrocyte migration and glial scar formation [4, 5] , astrocytic Ca 2+ signaling [6] , and striatal neurotransmitter release [7] .
With regard to the role of AQP4 in brain inflammation, AQP4 expression is associated with inflammation in multiple sclerosis, human immunodeficiency virus encephalitis or progressive multifocal leukoencephalopa-thy [8] , experimental autoimmune encephalomyelitis [9, 10] , neuromyelitis optica (NMO) [11, 12] , hemorrhage [13] or after intracerebral injection of lipopolysaccharide [14] or lysolecithin [15] . Especially in NMO, an inflammatory autoimmune demyelinating disease, AQP4 is a specific target because an IgG1 autoantibody (NMO-IgG) against AQP4 has been identified in the sera of a significant number of NMO patients [11, 12] . NMO-IgG down-regulates AQP4 in astrocytes, leads to the accumulation of toxic molecules and astrocyte dysfunction, and thereby results in demyelination and aggravates edema [12, 16, 17] . In these changes, NMOIgG-induced dysfunction of astrocytes is the determining event because activated astrocytes limit the development of inflammation [12, 18] . AQP4 is also important in astrocyte proliferation, one of the responses to inflammation, because AQP4 knockdown using siRNA inhibits astrocyte proliferation [19] .
However, the role of AQP4 in post-ischemic inflammation is poorly understood. Post-ischemic inflammation involves the accumulation of inflammatory cells (resident microglia and blood-derived leukocytes) and the induction of pro-inflammatory molecules [20] [21] [22] . As inflammatory mediators, cysteinyl leukotrienes (CysLTs) through activating their receptors (CysLT 1 and CysLT 2 ) evoke post-ischemic inflammation [23] [24] [25] [26] . CysLT 1 and CysLT 2 receptors are upregulated and localized in activated microglia and proliferated astrocytes in the ischemic brain in rats [24, 26] . The
CysLT 1 receptor regulates ischemia-induced astrocyte proliferation and glial scar formation as well [27, 28] . However, how AQP4 deficiency impacts the expression and localization of CysLT 1 and CysLT 2 receptors remains unknown.
In the present study, we investigated the inflammatory responses, i.e. accumulation of microglia and bloodderived leukocytes, and the expression of inflammationassociated CysLT 1 and CysLT 2 receptors, in AQP4-knockout (KO) mice.
Materials and methods
2.1 Animals AQP4-KO mice and matched CD1 littermates were kindly provided by Professor Gang HU, Nanjing Medical University, China. The AQP4-KO mice were generated as previously described [29] , housed at a controlled temperature (22 ± 1°C) under a 12-h light/dark cycle, and allowed free access to food and water. All experiments were approved by the Institutional Animal Care and Use
Committee of Zhejiang University School of Medicine.
Identification of AQP4 deficiency AQP4 expression
was determined by reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry. Total RNA extraction and cDNA synthesis were performed as reported previously [30, 31] . PCR was done on an Eppendorf Mastercy- The reactions were initially heated at 94°C for 1 min;
then at 94°C for 60 s, 60°C for 60 s and 72°C for 60 s, for a total of 35 cycles; and stopped at 72°C for 10 min.
PCR products of 10 μL were separated by 2% agarose gel electrophoresis and visualized by ethidium bromide staining.
The primer sequences were as follows: AQP4, forward International, Temecula, CA) as reported previously [32] .
Water intoxication was evaluated to determine the deficiency of AQP4 function. The mice were anesthetized by intraperitoneal injection of chloral hydrate (400 mg/kg), then intraperitoneally injected with 0.4 μg/kg 1-desamino-
8-d-arginine vasopressin (DDAVP), followed 30 min later
by distilled water injection of 20% of the body weight. The death rate was recorded at 10-min intervals within the initial 90 min and thereafter at 2-h intervals within 24 h [33] .
Focal cerebral ischemia
The mice were anesthetized by intraperitoneal injection of chloral hydrate (400 mg/kg).
A polyethylene catheter was inserted into the right femoral artery for continuous monitoring of blood pressure using a computer-assisted system (PC-Lab, Kelong Inc., Nanjing, China), and for measuring pO 2 , pCO 2 , and arterial 682 pH (Blood Gas Analyzer ABL 330, Leidu Inc., Denmark).
Blood glucose was monitored by a one-touch basic blood glucose monitoring system (Lifescan Inc., USA). Rectal temperature was measured and maintained at 37.0 ± 0.5°C with a heating pad and a heating lamp during surgery.
Focal cerebral ischemia was induced by middle cerebral artery occlusion (MCAO) as described previously [34] , based on modifications of a rat model originally described
by Longa et al. [35] . Briefly, a 6-0 nylon monofilament suture, blunted at the tip and coated with 1% poly-L-lysine, was inserted into the internal carotid artery, and advanced approximately 10 mm distal to the carotid bifurcation to occlude the origin of the middle cerebral artery. Thirty minutes after occlusion, the suture was withdrawn to allow reperfusion. In sham-operated animals, the same procedure was done with the exception of inserting the intraluminal filament. After surgery, mice were kept for about 2 h in a warm box heated by lamps to maintain body temperature. were used as secondary antibodies for 2 h at room temperature. The stained sections were examined under a fluorescence microscope (Olympus BX51). were loaded on 10% SDS-PAGE and blotted onto nitrocellulose membranes (Invitrogen). The membranes were then incubated overnight with the rabbit polyclonal anti-CysLT 1 or -CysLT 2 receptor antibody (1:200) that were prepared in our laboratory as reported previously [36, 37] The results of water intoxication showed that the survival of AQP4-KO mice was higher than wild-type mice (100% vs 58.3% at 60 min; 91.7% vs 50% at 90 min) (Fig. 1C) , which is consistent with a previous report [33] . These results confirmed the deficiency of the AQP4 gene in AQP4-KO mice. (Table 1) .
Histopathological and immunohistochemical examination

Western blotting analysis
Cellular responses in the brain after MCAO
At 24 h and 72 h after MCAO, the number of apparently surviving neurons with intact morphology was reduced in both the ischemic core and boundary zone. In the ischemic core more neurons were lost than in the boundary zone, and no surviving neurons were detectable at 72 h ( Fig. 2A) . Besides, AQP4-KO mice lost more neurons than wild-type mice at 24 h and 72 h in the boundary zone; while no difference was found in the ischemic core (Fig. 2B) . Immunostaining with anti-GFAP antibody showed that the number of astrocytes in both the ischemic core and boundary zone did not change 24 h after MCAO (data not shown). Astrocytes were not detectable in the ischemic core, but increased in the boundary zone 72 h after MCAO (Fig. 3A) . The increase in astrocytes compared to the sham-operated mice was significantly less in AQP4-KO mice than in wild-type mice (Fig. 3B ).
Immunostaining with anti-Iba-1 antibody showed that Iba-1-positive microglia did not substantially change in the ischemic core 24 h and 72 h after MCAO (data not shown).
However, the number of microglia increased in the boundary zone at 24 h and 72 h. The increased microglia at 72 h showed two types of morphology. Those in the inner periphery were hypertrophic and amoeboid, i.e. exhibited an activated morphology (Fig. 4A-b) , while those in the distant periphery were ramified, which corresponds to a relatively resting state (Fig. 4A-c) . In the boundary zone, the microglia were ramified at 24 h, and their density was not significantly different between wild-type and AQP4-KO mice (Fig. 4B) . At 72 h, however, the ramified microglia were significantly fewer but the numbers of activated microglia were higher in AQP4-KO mice than in wild-type mice (Fig. 4B, C) .
The number of MPO-positive neutrophils increased in the ischemic core 24 h and 72 h after MCAO (Fig. 5A ).
The cell density was significantly higher in AQP4-KO mice than in wild-type mice (Fig. 5B) . Taken together, these findings indicated that AQP4 KO aggravated the responses of i nflammatory cells but attenuated the astrocyte response in addition to aggravating neuronal loss in the ischemic brain. The expression of both receptors at 72 h was higher in AQP4-KO mice than in wild-type mice (Fig. 6) . The expression in AQP4-KO mice increased 156% and 71% more than in wild-type mice: CysLT 1 receptor (ratio to GAPDH),
Expression and localization of CysLT
1.46 ± 0.32 vs 0.57 ± 0.02 (n = 6, P <0.05, t-test); CysLT 2 receptor, 2.07 ± 0.22 vs 1.21 ± 0.12 (n = 6, P <0.
01, t-test).
Based on the spatiotemporal properties of the cellular responses to ischemia and reported findings [26, 30] , we CysLT 1 receptors were mainly localized in neurons and neutrophils, and no immunoreactivity was found in astrocytes and microglia (Fig. 7) . In the boundary zone at 72 h, CysLT 1 receptor was also found in most neurons, and in a few astrocytes and microglia. In AQP4-KO mice, the Cys-LT 1 receptor immunoreactivity was enhanced in neurons and neutrophils at 24 h in the ischemic core as well as in microglia at 72 h in the boundary zone compared to wildtype mice. The number of astrocytes at 72 h in the boundary zone was markedly reduced and they did not express the CysLT 1 receptor in AQP4-KO mice (Fig. 7) .
The localization pattern of CysLT 2 receptors was similar to that of CysLT 1 ; it was absent from the normal brain, increased in the ischemic core and mainly localized in neurons and neutrophils 24 h after MCAO. At 72 h, the CysLT 2 receptors were mainly localized in neurons and some in astrocytes and microglia in the boundary zone; however, the localization in microglia was markedly enhanced in AQP4-KO mice (Fig. 8) . We also found that, in the ischemic core 72 h after MCAO, neurons and astrocytes disappeared; the number of microglia was mildly increased but they did not express CysLT 1 and CysLT 2 receptors. The number of neutrophils was remarkably increased, and they expressed both receptors in AQP4-KO and wild-type mice (data not shown).
Discussion
The results of the present study suggest that AQP4
may play an inhibitory role in post-ischemic inflammation.
The evidence is that AQP4-KO mice exhibited more severe cellular inflammation after MCAO, including neutrophil infiltration in the ischemic core and microglial activation in the boundary zone, but the proliferation of astrocytes was attenuated. Moreover, the up-regulated expression of the inflammation-related receptors CysLT 1 and CysLT 2 and their localization in injured neurons, infiltrating neutrophils and activated microglia were enhanced in AQP4-KO mice.
We found that astrocyte proliferation in the boundary zone 72 h after MCAO was attenuated in AQP4-KO mice;
such an inhibition could also be induced by knockdown of AQP4 using siRNA in vitro [19] . The attenuated astrocyte responses might be related to aggravated cellular inflammation in AQP4-KO mice. Supporting this notion, astrocyte dysfunction induced by NMO-IgG accelerates the development of inflammation [12] . Moreover, either ablation or attenuation of glial scar-forming astrocytes exacerbates the spread of inflammatory cells during locally-initiated inflammatory responses to brain trauma or spinal cord injury [38] [39] [40] [41] , or during peripherally-initiated experimental autoimmune encephalomyelitis [18, 42] . As another possibility, the numbers of CD4 + CD25 + regulatory T cells are reduced in AQP4-KO mice [43] , suggesting that AQP4 KO disrupts immunosuppressive regulators, thereby resulting in hyperactive immune and inflammatory responses.
The aggravated cellular inflammation might, in turn, be one of the factors that induce more severe neuronal injury after MCAO in AQP4-KO mice, because inflammatory cells, both activated microglia and infiltrating neutrophils, express and release pro-inflammatory mediators such as the toxic cytokines IL-1 and TNF-α [44, 45] . Reduction of glutamate uptake and the expression of the excitatory amino-acid transporter GLT-1 in astrocytes of AQP4-KO mice [46] might also worsen the neuronal injury by potentiating excitatory toxicity in the acute phase of ischemia.
Another important finding is that AQP4-KO mice have been reported in rat brain after MCAO [26, 30] . However, in the present study we focused on the delayed phase (72 h) to reveal the inflammatory responses in AQP4-KO mice.
The spatiotemporal patterns imply that the enhanced CysLT 1 and CysLT 2 receptors in AQP4-KO mice might be associated with aggravation of post-ischemic neuronal injury and inflammatory responses. Why AQP4-KO mice exhibited an enhanced up-regulation of CysLT 1 and CysLT 2 receptors cannot be explained in the present study. However, one of the possibilities is that the enhanced inflammatory responses due to astrocyte dysfunction may, via a series of events, secondarily potentiate inflammation-related molecules in AQP4-KO mice [12, 16, 17] ; the up-regulation of CysLT 1 and such as cytokines, chemokines, oxygen and nitrogen free radicals and matrix metalloproteinases [47] may also respond to aggravated inflammation in AQP4-KO mice.
Our findings suggest that AQP4 KO may aggravate ischemic insults, i.e. more severe cellular inflammation and neuronal injury, and profoundly up-regulated CysLT 1 and CysLT 2 receptors. In other words, AQP4 may be a suppressing or protective regulator of post-ischemic inflammation. The protective role of AQP4 in ischemic brain injury is also reported elsewhere. For example, the early induction of AQP4 by a low dose of thrombin contributes to limitation of the ischemic infarction and formation of edema in mice [48] , and acute vascular disruption is associated with AQP4 loss after transient MCAO in rats [49] . This protective role is also reported in spinal cord compression injury [50] , subarachnoid hemorrhage [51] , intracerebral hemorrhage [52] and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity [53, 54] . These findings demonstrate that AQP4 in astrocytes exerts a beneficial action in pathological conditions. However, AQP4 has also been reported to exert an injurious action in an early phase of brain ischemia, as APQ4 deficiency attenuates cytotoxic edema and the resultant ischemic insult after permanent focal cerebral ischemia [1, 33] . This different finding might be due to different ischemic models and observed indicators, and in the present study we focused on cellular and molecular inflammatory responses at 24 h and 72 h after transient focal cerebral ischemia in AQP4-KO mice. Because post-ischemic responses are highly complex, the role of AQP4 in postischemic inflammation and repair processes in the delayed or chronic phases needs further investigation.
In conclusion, we found that AQP4-KO mice exhibited more severe cellular inflammation and enhanced expression of the inflammation-related CysLT 1 and CysLT 2 receptors after MCAO, suggesting that AQP4 may play an inhibitory role in post-ischemic inflammation.
